14d
The Slovak Spectator on MSNMan attacked by knife in Bratislava, supposedly for Hungarian originLast Friday night, a knife attack occured at Šafárikovo Námestie square in Bratislava's centre. An unidentified man attacked ...
Polish authorities have disrupted a clandestine Russian sabotage ring operating near Warsaw, thwarting multiple acts of ...
SK Capital Partners Acquires Physical Properties Testers ("PPT") Group Limited From Battery Ventures
HALIFAX, England, March 06, 2025--(BUSINESS WIRE)--Funds advised by SK Capital Partners, LP ("SK Capital"), a private investment firm focused on the specialty materials, ingredients, and life ...
SK Capital Partners Acquires Physical Properties Testers (“PPT”) Group Limited From Battery Ventures
HALIFAX, England--(BUSINESS WIRE)--Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors ...
SK Capital Partners Acquires Physical Properties Testers (“PPT”) Group Limited From Battery Ventures
Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, completed the acquisition of ...
6h
The Slovak Spectator on MSNBratislava’s Nové Mesto will soon have its own skatepark, on Kuchajda lakeBratislava’s borough of Nové Mesto will soon have its own skatepark. It will be located next to the Kuchajda lake, a popular ...
SK Capital Partners Acquires Physical Properties Testers ("PPT") Group Limited From Battery Ventures
HALIFAX, England, March 06, 2025--(BUSINESS WIRE)--Funds advised by SK Capital Partners, LP ("SK Capital"), a private investment firm focused on the specialty materials, ingredients, and life sciences ...
Bluebird Bio (BLUE) announced that it has entered into a definitive agreement to be acquired by funds managed by Carlyle (CG) and SK Capital Partners. David Meek, former CEO of Mirati Therapeutics ...
Carlyle and SK Capital will provide bluebird primary capital to scale bluebird’s commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral ...
Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results